안국약품(주)

R&D History

Ahngook Pharm is based on continuous research
We create innovative solutions.

R&D History

  • 2020~

    • 2021

      Signed an MOU with the Korea Polar Research Institute for development of anti-dementia drugs
      Spun off a bio venture with the bispecific antibody technology.
      Launched health functional food “V-PACK,” a multi-vitamin
      Released Lipozet, Yoosmezole DR, SOS tab., and Superdia tab.

    • 2020

      Submitted the local patent application for the original bispecific antibody technology
      Released Forlax 4g in partnership with French Ipsen Pharma
      Released Anyflu powder, Lipizero, Humega Mini, Circaton PR Tab., Raperon Inj., and Futidine

  • 2010~

    • 2019

      Signed a joint research agreement with DGIST (Daegu Gyeongbuk Institute of Science and Technology)
      Signed a joint research agreement with Repigen
      Marketed Newrayla Tab., Pevaro Tab., Heparoad Tab., Pevaro S Cap., and Sapopello SR Tab

    • 2018

      Participated in the AI New Drug Development Promotion Team, hosted by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association
      Published research results about active ingredient of ‘Synatura syrup’ on the efficacy for the treatment of yellow dust-related lung inflammation
      Launched Medifer, ‘lutein ampoule for external use’ Medifer
      Obtained “ISO 37001” certification, anti-bribery management system
      Released Telmiroad Q Tab . (IMD)

    • 2017

      Released Rupafin Tab., in partnership with Spanish Uriach
      Released Bowel-cleaning IMD, Coolipa Solution
      Released Suvazet Tab. (IMD)

    • 2016

      Released Binosto Effervescent Tab. (IMD) in partnership with Spanish EffRx
      Released the Korea’s first high-dose PPI, Retopra Tab. 40mg
      Released a body vitamin, Tobicom Gold Tab.

    • 2015

      Released Levomos Tab., an isomer IMD
      Released Greseo Powder OD!FS, a newly formulated impotence drug

    • 2013

      Released Levosartan Tab., an isomer IMD
      Released Distec Tab., a nature-derived IMD

    • 2012

      Released Retopra Tab., an isomer IMD

    • 2011

      Released an antitussive drug, Synatura Syrup with synergic effects

  • 2000~

    • 2009

      Released an antitussive drug, Anycough Cap.

    • 2008

      Released a Needle-Free Injection System, INJEX
      Signed a distribution contract for HPV DNA CHIP
      Signed a License Contract for Shiulinjia, a hepatic protector

    • 2007

      Opened the Company’s Central R&D Center (Nature-derived Product R&D Center) within the Gyeonggi Bio Center
      Release a urinary incontinence, Sedatol SR Tab
      Released a complex digestant, Grandpaze F Tab.
      Signed the Distribution Contract for a Needle-Free Injection System, INJEX

    • 2006

      Signed a contract for moving into “Osong Biovalley” in Cheongju
      Developed a hypertension drug, Levotension Tab. (Korea’s first S-AMLODIPINE formulation)
      Developed a hypertension drug, Levotenol Tab. (Korea’s first S-ATENOLOL formulation)
      Released a complex digestant, Grandpaze F Soft Cap.

    • 2004

      Built a synthesis plant in Hyangnam

    • 2003

      Released a constipation drug, Forlax powder, in partnership with French BEAUFOUR IPSEN

    • 2001

      Released an anti-inflammatory painkiller, Anyfen Tab.

    • 2000

      Released an antitussive drug, Prospan Syrup, in partnership with German ENGELHARD

  • 1990~

    • 1998

      Released a peptic ulcer drug, Anytal triple layer Tab.

    • 1995

      Released a digestant, Grandpaze triple layer Tab.

    • 1994

      Released an eye nutrient, Tobicom S